Program Patient Safety Lead (Slough, Berkshire, GB) en Inspired by Patients. Driven by Science.

Make your mark for patients

We are looking for a Program Patient Safety Lead who is passionate, agile, and detail-oriented to strengthen our Early Clinical Development Benefit Risk and Medical Safety Unit team. This role can be based in one of our hubs in Braine l’Alleud, Belgium (preferred); Slough, UK; or Raleigh, US.

About the role

The Candidate Benefit Risk Lead is accountable for the strategic planning, communication, and delivery of benefit-risk assessments and risk management strategy (Benefit-risk assessment plan; BRAP) for assigned clinical-stage candidates. This includes identifying emerging safety concerns, evaluating benefit-risk outcomes, and developing effective risk management strategies.

Who you'll work with

You will work transversally with multiple UCB stakeholders (Clinical Development, Quantitative Clinical Pharmacology, Regulatory, Statistics and Non-clinical Safety amongst others) and patients to drive and implement program safety strategies. You’ll lead the cross-functional Benefit Risk Team (BRT), empowering and inspiring team members to take ownership of their responsibilities and use data-driven insights to inform decisions.

What you'll do

• Drive the program-specific safety strategy and ensure high-quality BRAP outputs with clarity, transparency, and key messaging.
• Implement safety monitoring and risk management strategies in collaboration with cross-functional teams.
• Communicate insights to support decision-making at internal governance bodies (eg. EDM, PPC, BRB).
• Analyze and interpret safety data (clinical, regulatory, legal, product quality) to identify potential new risks.
• Author and review documents in accordance with global clinical development strategy and regulatory submission requirements.
• Apply innovative approaches and technologies for data collection, documentation, and evidence generation.
• Make ethical decisions aligned with UCB’s values, prioritizing patient safety and regulatory compliance.

Interested? We’re looking for:

• MD preferred , PhD, PharmD or equivalent with relevant experience
• Significant experience in early clinical development (first in human to proof of concept) and risk management; preferably in industry environment.
• Experience in Phase 1 trials and/or Gene Therapy is highly preferred.
• Strong knowledge of Good Clinical Practice and international drug safety regulations.
• Demonstrated leadership in complex, dynamic environments with short timelines and ambiguity.
• Cross-functional collaboration skills to ensure credible communication with the external medical and scientific community and for internal communication.
• Excellent English communication skills—verbal, written, and presentation skills
• Proficient and positive attitude toward using digital tools

Are you ready to ‘go beyond’ to create value and make your mark for patients? If this sounds like you, then we would love to hear from you! 

About us 
UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are around 8,500 people in all four corners of the globe, inspired by patients and driven by science. 

Why work with us? 
At UCB, we don’t just complete tasks, we create value. We aren’t afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We ‘go beyond’ to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential. 

UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.
 
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on [email protected]. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.